Alpha-1 Antitrypsin Deficiency-associated Liver Disease
Alpha-1 antitrypsin (AAT) deficiency (AATD) is a rare inherited condition that can lead to liver disease (AATLD) in children and liver and lung disease in adults. The disorder is caused by mutations in the SERPINA1 gene, which provides instructions for making the AAT protein. In people with AATLD, the liver produces an abnormal version of the AAT protein, which is prone to aggregation in the liver. This accumulation of mutated AAT in the liver can lead to liver disease. Individuals with AATLD also have an increased risk of having lung disease.
Research suggests that people who have the pair of gene variants called “ZZ” are most commonly identified as having AATLD. Recent epidemiology research indicates that approximately 120,000 individuals in Europe and 63,000 individuals in the U.S. carry this ZZ genotype; the genotype occurs most frequently in individuals of Northern European descent. An estimated 10% or more of adults with AAT deficiency develop clinically meaningful liver disease, and recent research suggests that AATLD is both underrecognized and underdiagnosed.
Hamesch K, Mandorfer M, Pereira VM, Moeller LS, Pons M, et. al. European Alpha1-Liver Study Group. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation. Gastroenterology. 2019 Sep;157(3):705-719.e18. doi: 10.1053/j.gastro.2019.05.013. Epub 2019 May 20. PMID: 31121167.
Tanash, H. A., & Piitulainen, E. (2019). Liver disease in adults with severe alpha-1-antitrypsin deficiency. Journal of gastroenterology, 54(6), 541–548. doi:10.1007/s00535-019-01548-y
EU congenital AAT deficiency based on Dicerna internal estimates.
Resources for patients with AAT deficiency
The following organizations provide educational resources and support research to help people living with AAT deficiency.